Login

A conversation with William Ma, Global CIO of GROW Investment Group, hosted by Alvin Fan, CEO of OP Investment Management, filmed on 28 Nov 2023. 00:10:00

Share On Facebook Share On Twitter

Alvin Fan, CEO of OP Investment Management

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
EGM Milan Meeting: Connecting Investors with Leading Companies like Comal SPA | Alfredo Balletti, CEO, Indo National Ltd.
00:10:00
Blue Bonds: Unlocking the Blue Economy's Potential - Insights from Matt Lawton and Tongai Kunorubwe at T. Rowe Price
00:10:00
Interview with Fura Gems at One-to-One Mining Investment Conference in Cape Town
00:10:00
Growth and profitability must be met with good governance says venture capitalist|Yinglan Tan,Founding Managing Partner,Insignia Ventures Partners
00:10:00
Renewable Energy Innovator Explores Carbon Abatement Solutions and Profitability | Dr Jessica North, CEO, Lgi Ltd.
00:10:00
Mark Leader's Commitment to Cancer Research | Mark Leader, Co-CEO and Co-Founder, Sun Capital Partners.
00:10:00
Focuses on investing in early-stage digital health companies that will redefine healthcare|Lynne Chou O'Keefe,Founder and Managing Partner,Define Ventures
00:10:00
Blackstone Minerals talks early cashflow and partnering opportunities for Ta Khoa Project | Thomas L. Carter, CEO, Black Stone Minerals LPBSM:NYQ
00:10:00
Building a billion dollar business and hitting $100M ARR|Murat Bicer,partner,CRV
00:10:00
Malcolm from Manley Resources Discusses Recent Developments
00:10:00
SM Ventures into Logistics with 2GO Express, Inc. | Mr. Frederic C. Dybuncio - President/Chief Executive Officer at 2go group inc
00:10:00
Debating the War on Drugs: Ed Meese vs. Joe McNamara|Edwin Meese

© 2026 Nehu